NCT00188136View on ClinicalTrials.gov

Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2010

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Melphalan, ATG, Fludarabine

allo Tx during aplasia

Trial Locations (1)

01307

University hospital Carl Gustav Carus, Dresden

All Listed Sponsors
lead

University Hospital Carl Gustav Carus

OTHER

NCT00188136 - Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML) | Biotech Hunter | Biotech Hunter